58 related articles for article (PubMed ID: 31592730)
1. Hepatobiliary versus Extracellular MRI Contrast Agents in Hepatocellular Carcinoma Detection: Hepatobiliary Phase Features in Relation to Disease-free Survival.
Kim DK; An C; Chung YE; Choi JY; Lim JS; Park MS; Kim MJ
Radiology; 2019 Dec; 293(3):594-604. PubMed ID: 31592730
[TBL] [Abstract][Full Text] [Related]
2. Characterization of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI via contrast-enhanced ultrasound using perfluorobutane.
Bae JS; Lee JY; Suh KS; Hong SK; Yoon JH; Kim YJ; Yu SJ; Lee JH; Cho EJ; Lee YB; Han JK
Abdom Radiol (NY); 2023 Jul; 48(7):2321-2330. PubMed ID: 37097451
[TBL] [Abstract][Full Text] [Related]
3. Detection of arterial phase hyperenhancement of small hepatocellular carcinoma with MRI: Comparison between single arterial and multi-arterial phases and between extracellular and hepatospecific contrast agents.
Bouyer T; Roux M; Jacquemin S; Dioguardi Burgio M; Sutter O; Laurent-Croisé V; Lonjon J; Bricault I; Trillaud H; Rode A; Aubé C; Paisant A
Diagn Interv Imaging; 2023 Oct; 104(10):477-484. PubMed ID: 37211446
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetic acid in hepatocellular carcinoma and liver metastases: pearls and pitfalls.
Kwok HM; Chau CM; Lee HCH; Wong T; Chan HF; Luk WH; Yung WTA; Cheng LF; Ma KFJ
Clin Radiol; 2023 Oct; 78(10):715-723. PubMed ID: 37453807
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma.
Yokoo T; Masaki N; Parikh ND; Lane BF; Feng Z; Mendiratta-Lala M; Lee CH; Khatri G; Marsh TL; Shetty K; Dunn CT; Al-Jarrah T; Aslam A; Davenport MS; Gopal P; Rich NE; Lok AS; Singal AG
Radiology; 2023 Apr; 307(2):e220917. PubMed ID: 36692401
[TBL] [Abstract][Full Text] [Related]
6. Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection.
Jiang H; Yang C; Chen Y; Wang Y; Wu Y; Chen W; Ronot M; Chernyak V; Fowler KJ; Bashir MR; Song B
Radiology; 2023 Nov; 309(2):e230527. PubMed ID: 37934100
[TBL] [Abstract][Full Text] [Related]
7. MRI Using Gadoxetic Acid in the Work-Up of Liver Nodules Not Conclusively Benign in Budd-Chiari Syndrome: A Prospective Long-Term Follow-Up.
García-Criado Á; Rimola J; Seijo S; Darnell A; Belmonte E; Sapena V; Moreno-Rojas J; Pérez V; Hernández-Gea V; Ayuso C; Reig M; García-Pagán JC; Bruix J
Liver Cancer; 2024 Apr; 13(2):203-214. PubMed ID: 38751551
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging-based risk factors of hepatocellular carcinoma after direct-acting antiviral therapy: A multicenter observational study.
Ichikawa S; Motosugi U; Sawai Y; Ishida H; Imai Y; Kozaka K; Tsurusaki M; Sofue K; Murakami T; Kawai N; Matsuo M; Fukukura Y; Mawatari S; Shimizu T; Morisaka H; Inoue T; Goshima S
Hepatol Res; 2024 Jan; 54(1):43-53. PubMed ID: 37676063
[TBL] [Abstract][Full Text] [Related]
9. Abbreviated MRI for Hepatocellular Carcinoma Screening and Surveillance.
An JY; Peña MA; Cunha GM; Booker MT; Taouli B; Yokoo T; Sirlin CB; Fowler KJ
Radiographics; 2020; 40(7):1916-1931. PubMed ID: 33136476
[TBL] [Abstract][Full Text] [Related]
10. Preoperative prediction of cholangiocyte phenotype hepatocellular carcinoma on contrast-enhanced MRI and the prognostic implication after hepatectomy.
Chen Y; Chen J; Yang C; Wu Y; Wei H; Duan T; Zhang Z; Long L; Jiang H; Song B
Insights Imaging; 2023 Nov; 14(1):190. PubMed ID: 37962669
[TBL] [Abstract][Full Text] [Related]
11. Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Counterpoint-Hepatobiliary Contrast Agents Improve Detection and Characterization.
Zhang LX; Tang A
AJR Am J Roentgenol; 2024 Apr; 222(4):e2330140. PubMed ID: 37791733
[No Abstract] [Full Text] [Related]
12. Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Point-Why Extracellular Contrast Agents Are Superior for This Task.
Tamandl D; Schima W
AJR Am J Roentgenol; 2024 Apr; 222(4):e2330254. PubMed ID: 37791731
[No Abstract] [Full Text] [Related]
13. Cerebellar Metastasis Manifesting as a Cyst with Mural Nodule(s): Differentiating It From Hemangioblastoma on MRI.
Chen X; Li F; Xu G; Su J; Shi Q; Dai H
World Neurosurg; 2023 Jul; 175():e994-e1004. PubMed ID: 37087031
[TBL] [Abstract][Full Text] [Related]
14. Ocular MRI Findings in Patients with Severe COVID-19: A Retrospective Multicenter Observational Study.
Lecler A; Cotton F; Lersy F; Kremer S; Héran F;
Radiology; 2021 May; 299(2):E226-E229. PubMed ID: 33591889
[TBL] [Abstract][Full Text] [Related]
15. Editorial for "Beta-Catenin-Mutated Hepatocellular Adenomas at Hepatobiliary Phase MRI: A Systematic Review and Meta-Analysis".
Schmidt S; Sempoux C
J Magn Reson Imaging; 2024 Mar; ():. PubMed ID: 38426593
[No Abstract] [Full Text] [Related]
16. New understanding of hepatobiliary MRI.
Pastor CM; Vilgrain V
Nat Rev Gastroenterol Hepatol; 2024 Apr; ():. PubMed ID: 38565648
[No Abstract] [Full Text] [Related]
17. Gadoxetic acid-enhanced MR imaging for hepatocellular carcinoma: molecular and genetic background.
Kitao A; Matsui O; Yoneda N; Kozaka K; Kobayashi S; Koda W; Inoue D; Ogi T; Yoshida K; Gabata T
Eur Radiol; 2020 Jun; 30(6):3438-3447. PubMed ID: 32064560
[TBL] [Abstract][Full Text] [Related]
18. Liver Lesions at Risk of Transformation into Hepatocellular Carcinoma in Cirrhotic Patients: Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement.
Brandi N; Renzulli M
J Clin Transl Hepatol; 2024 Jan; 12(1):100-112. PubMed ID: 38250460
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary phase imaging in cirrhotic patients using compressed sensing and controlled aliasing in parallel imaging results in higher acceleration.
Yoon S; Shim YS; Park SH; Sung J; Nickel MD; Kim YJ; Lee HY; Kim HJ
Eur Radiol; 2024 Apr; 34(4):2233-2243. PubMed ID: 37731096
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
